NICOLE GUZMAN: Open Payments
NPI 1669154993 · ROCKWALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 12 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $96 · 2025 $371
Food & beverage: $259Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $144 |
| Axsome Therapeutics, Inc. | 3 | $84 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Alkermes, Inc. | 1 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
Products named: Auvelity, REXULTI, CAPLYTA, UZEDY, ARISTADA, TRINTELLIX.
Industry payments across TX — which companies pay providers there.
